Breast Cancer
Show Only Open Trials
1.
A Phase II Study of Tetrathiomolybdate (TM) in patients with breast cancer at moderate to high risk of recurrence
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: High-Risk Stage II Breast Cancer; Stage III Breast Cancer; Stage IV Breast Cancer in Remission
2.
S0221: Phase III Trial of Continuous Schedule AC + G Vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High-Risk Node Negative Breast Cancer
- Study Status: Closed to Enrollment
- Sponsor: SouthWest Oncology Group (SWOG) and The Cancer Support Trials Unit (CTSU)
- Disease Status and/or Stage: Operable Stage 1, II or II Invasive Breast Cancer
3.
Prospective Data Collection Among Women Using Cold Caps During TC Chemotherapy
- Study Status: Open to Enrollment
- Disease Status and/or Stage: Early-Stage Breast Cancer
4.
A Phase I Study of 177Lu Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-591) in Patients with Nonprostate Metastatic Solid Tumors: A Pilot Study
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College
- Disease Status and/or Stage: Metastatic Solid Tumor
5.
A Phase I/II, Open-Label, Dose Escalation Study of CDX-1401 in Patients with Malignances Known to Express NY-ESO-1
- Study Status: Closed to Enrollment
- Sponsor: Celldex Therapeutics
- Disease Status and/or Stage: Progressive Disease after therapies with curative potential or approved salvage regimen
6.
A Phase II, Multicenter, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients with Advanced Breast Cancer
- Study Status: Open to Enrollment
- Sponsor: Eisai
- Disease Status and/or Stage: Advanced Breast Cancer and Neuropathy
7.
E5103: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
- Study Status: Open to Enrollment
- Sponsor: Eastern Cooperative Oncology Group; National Cancer Institute
- Disease Status and/or Stage: Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
8.
A Phase I-II Study of R115777 (Tipifarnib, Zarnestraâ) Plus Sequential Weekly Paclitaxel followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients with Stage IIB-IIIC Breast Cancer
- Study Status: Open to Enrollment
- Sponsor: New York Cancer Consortium; National Cancer Institute
- Disease Status and/or Stage: Stage IIB-IIC Breast Cancer
9.
Phase II study of ixabepilone in patients with metastatic breast cancer and a prospective evaluation of its effects on the ultrastructure of neurons
- Study Status: Open to Enrollment
- Sponsor: Weill Cornell Medical College; Bristol-Myers Squibb
- Disease Status and/or Stage: Metastatic Breast Cancer
10.
ACOSOG Z1072: A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma
- Study Status: Open to Enrollment
- Sponsor: American College of Surgeons/National Cancer Institute
- Disease Status and/or Stage: Invasive Breast Cancer
11.
A Phase II, Single-Arm, Multi-Center Study Evaluating the Combination of Vinorelbine and Lapatinib in Women with ErbB2 Overexpressing Metastatic Breast Cancer
- Study Status: Closed to Enrollment
- Sponsor: GlaxoSmithKline
- Disease Status and/or Stage: Metastatic Breast Cancer
12.
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism (VTE) in Patients with Cancer
- Study Status: Closed to Enrollment
- Disease Status and/or Stage: Any Stage of Cancer
13.
A Randomized Placebo-Controlled Trial of Glutamine to Reduce the Signs and Symptoms of Peripheral Neuropathy in Breast Cancer Patients with a Mild Peripheral Neuropathy Receiving Paclitaxel Chemotherapy
- Study Status: Open to Enrollment
- Disease Status and/or Stage: Breast Cancer, any stage
14.
A Phase II Study of Tetrathiomolydate (TM) in patients with breast cancer at moderate to high risk for recurrence
- Study Status: Open to Enrollment
- Disease Status and/or Stage: Breast Cancer at moderate to high risk of recurrence (based on the number of lymph nodes); Stage 4 breast cancer without any evidence of disease
